These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 18378328)

  • 1. Delayed aversive effects of high-dose fentanyl. Prevention by a polyamine-deficient diet.
    Pain L; Oberling P; Mainsongeon M; Moulinoux JP; Simonnet G
    Behav Brain Res; 2008 Jun; 190(1):119-23. PubMed ID: 18378328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fentanyl dose and exposure duration on the affective and somatic signs of fentanyl withdrawal in rats.
    Liu J; Pan H; Gold MS; Derendorf H; Bruijnzeel AW
    Neuropharmacology; 2008 Oct; 55(5):812-8. PubMed ID: 18634811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The median effective dose of ketamine and gabapentin in opioid-induced hyperalgesia in rats: an isobolographic analysis of their interaction.
    Van Elstraete AC; Sitbon P; Benhamou D; Mazoit JX
    Anesth Analg; 2011 Sep; 113(3):634-40. PubMed ID: 21642613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gabapentin prevents delayed and long-lasting hyperalgesia induced by fentanyl in rats.
    Van Elstraete AC; Sitbon P; Mazoit JX; Benhamou D
    Anesthesiology; 2008 Mar; 108(3):484-94. PubMed ID: 18292686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fentanyl pretreatment on regional cerebral blood flow in focal cerebral ischemia in rats.
    Chi OZ; Hunter C; Liu X; Chokshi SK; Weiss HR
    Pharmacology; 2010; 85(3):153-7. PubMed ID: 20150753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in morphine reward in a model of neuropathic pain.
    Cahill CM; Xue L; Grenier P; Magnussen C; Lecour S; Olmstead MC
    Behav Pharmacol; 2013 Jun; 24(3):207-13. PubMed ID: 23591124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrous oxide (N2O) prevents latent pain sensitization and long-term anxiety-like behavior in pain and opioid-experienced rats.
    Bessière B; Richebé P; Laboureyras E; Laulin JP; Contarino A; Simonnet G
    Neuropharmacology; 2007 Nov; 53(6):733-40. PubMed ID: 17884109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone-induced conditioned place aversion following a single dose of morphine in the rat.
    White DA; Hwang ML; Holtzman SG
    Pharmacol Biochem Behav; 2005 Jul; 81(3):451-8. PubMed ID: 15907990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sevoflurane on carrageenan- and fentanyl-induced pain hypersensitivity in Sprague-Dawley rats.
    Richebé P; Rivalan B; Rivat C; Laulin JP; Janvier G; Maurette P; Simonnet G
    Can J Anaesth; 2009 Feb; 56(2):126-35. PubMed ID: 19247760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A test of the opponent-process theory of motivation using lesions that selectively block morphine reward.
    Vargas-Perez H; Ting-A-Kee RA; Heinmiller A; Sturgess JE; van der Kooy D
    Eur J Neurosci; 2007 Jun; 25(12):3713-8. PubMed ID: 17610590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid modulation of reflex versus operant responses following stress in the rat.
    King CD; Devine DP; Vierck CJ; Mauderli A; Yezierski RP
    Neuroscience; 2007 Jun; 147(1):174-82. PubMed ID: 17521823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-dependent effects of periadolescent exposure to the cannabinoid agonist CP-55,940 on morphine self-administration behaviour and the endogenous opioid system.
    Biscaia M; Fernández B; Higuera-Matas A; Miguéns M; Viveros MP; García-Lecumberri C; Ambrosio E
    Neuropharmacology; 2008 Apr; 54(5):863-73. PubMed ID: 18329053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in effects of predictable and unpredictable footshock on fentanyl self-administration in rats.
    Klein LC; Popke EJ; Grunberg NE
    Exp Clin Psychopharmacol; 1997 May; 5(2):99-106. PubMed ID: 9234044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidural ketamine potentiates epidural morphine but not fentanyl in acute nociception in rats.
    Hoffmann VL; Baker AK; Vercauteren MP; Adriaensen HF; Meert TF
    Eur J Pain; 2003; 7(2):121-30. PubMed ID: 12600793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine sex-dependently induced place conditioning in adult Wistar rats.
    Karami M; Zarrindast MR
    Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers.
    Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
    Clin Ther; 2006 May; 28(5):707-14. PubMed ID: 16861092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rewarding and reinforcing effects of the NMDA receptor antagonist-benzodiazepine combination, Zoletil®: difference between acute and repeated exposure.
    de la Peña JB; Lee HC; de la Peña IC; Woo TS; Yoon SY; Lee HL; Han JS; Lee JI; Cho YJ; Shin CY; Cheong JH
    Behav Brain Res; 2012 Aug; 233(2):434-42. PubMed ID: 22659394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high-dose of fentanyl induced delayed anxiety-like behavior in rats. Prevention by a NMDA receptor antagonist and nitrous oxide (N(2)O).
    Bessière B; Laboureyras E; Ben Boujema M; Laulin JP; Simonnet G
    Pharmacol Biochem Behav; 2012 Oct; 102(4):562-8. PubMed ID: 22796204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical effect of chronic fentanyl treatment on naltrexone-induced supersensitivity and upregulation.
    Ayesta FJ; Ableitner A; Emmett-Oglesby MW; Herz A; Shippenberg TS
    J Pharmacol Exp Ther; 1992 Jan; 260(1):168-74. PubMed ID: 1731036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.